Cordance

Cordance is a new QEEG method which combines complementary information from absolute (the amount of power in a frequency band at a given electrode) and relative power (the percentage of power contained in a frequency band relative to the total spectrum) of EEG spectra.^[1]

Cordance is a measure of regional brain activity. It is computed using quantitative electroencephalographic (QEEG) measures of brain wave patterns in an algorithm developed at the UCLA Laboratory of Brain, Behavior, and Pharmacology by Drs. Andrew Leuchter and Ian Cook.

In comparison with other QEEG measures, such as absolute power or relative power, cordance appears to have a superior correlation with regional brain perfusion, one of the other standard measures of regional brain activity. Because cordance is derived from EEG signals, assessments of brain function with cordance do not require the use of radioactive tracer molecules, as is the case with some other functional neuroimaging methods (PET or SPECT scanning).

Cordance has been applied to studying brain activity in a variety of neurological and psychiatric disorders. A major area of study has been major depressive disorder, in efforts to develop biomarkers that could help guide treatment. This line of work was begun in the mid 1990s at UCLA and is now the subject of replication studies at other medical centers.

References

1. ^ Bares, M.; Brunovsky, M.; Kopecek, M.; Novak, T.; Stopkova, P.; Kozeny, J.; Sos, P.; Krajca, V. et al. (2008). "Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder". European Psychiatry 23 (5): 350–355. doi:10.1016/j.eurpsy.2008.03.001. PMID 18450430.  edit